These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11305707)

  • 1. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
    Hollander E; Allen A; Lopez RP; Bienstock CA; Grossman R; Siever LJ; Merkatz L; Stein DJ
    J Clin Psychiatry; 2001 Mar; 62(3):199-203. PubMed ID: 11305707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.
    Simeon D; Baker B; Chaplin W; Braun A; Hollander E
    CNS Spectr; 2007 Jun; 12(6):439-43. PubMed ID: 17545954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.
    Kavoussi RJ; Coccaro EF
    J Clin Psychiatry; 1998 Dec; 59(12):676-80. PubMed ID: 9921702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open trial of valproate in borderline personality disorder.
    Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
    J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.
    Nickel MK; Nickel C; Mitterlehner FO; Tritt K; Lahmann C; Leiberich PK; Rother WK; Loew TH
    J Clin Psychiatry; 2004 Nov; 65(11):1515-9. PubMed ID: 15554765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
    Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
    Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine in the treatment of borderline personality disorder: a pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2005 Sep; 66(9):1111-5. PubMed ID: 16187767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders.
    Hollander E; Tracy KA; Swann AC; Coccaro EF; McElroy SL; Wozniak P; Sommerville KW; Nemeroff CB
    Neuropsychopharmacology; 2003 Jun; 28(6):1186-97. PubMed ID: 12700713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline predictors of response to divalproex in conduct disorder.
    Saxena K; Silverman MA; Chang K; Khanzode L; Steiner H
    J Clin Psychiatry; 2005 Dec; 66(12):1541-8. PubMed ID: 16401155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.
    Zanarini MC; Schulz SC; Detke HC; Tanaka Y; Zhao F; Lin D; Deberdt W; Kryzhanovskaya L; Corya S
    J Clin Psychiatry; 2011 Oct; 72(10):1353-62. PubMed ID: 21535995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.
    Loew TH; Nickel MK; Muehlbacher M; Kaplan P; Nickel C; Kettler C; Fartacek R; Lahmann C; Buschmann W; Tritt K; Bachler E; Mitterlehner F; Pedrosa Gil F; Leiberich P; Rother WK; Egger C
    J Clin Psychopharmacol; 2006 Feb; 26(1):61-6. PubMed ID: 16415708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Zanarini MC; Frankenburg FR
    Am J Psychiatry; 2003 Jan; 160(1):167-9. PubMed ID: 12505817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Linehan MM; McDavid JD; Brown MZ; Sayrs JH; Gallop RJ
    J Clin Psychiatry; 2008 Jun; 69(6):999-1005. PubMed ID: 18466045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial.
    Steiner H; Petersen ML; Saxena K; Ford S; Matthews Z
    J Clin Psychiatry; 2003 Oct; 64(10):1183-91. PubMed ID: 14658966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.
    Hollander E; Soorya L; Wasserman S; Esposito K; Chaplin W; Anagnostou E
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):209-13. PubMed ID: 16316486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.